Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil for Prevention of Keloid Recurrence
NCT01720056Phase 4Terminated
- Sponsor
- The University of Western Australia
- Start
- Oct 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of verapamil in keloid, sponsored by The University of Western Australia. Started Oct 2012; status: terminated.
02
Drugs
verapamil
03
Conditions
keloid
Beyond the preview
Go deeper on NCT01720056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01720056.